Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications
about
Translational Significance of Heme Oxygenase in Obesity and Metabolic SyndromeCYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype.HCC development is associated to peripheral insulin resistance in a mouse model of NASH.Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.Eicosanoids in metabolic syndrome.Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial FunctionLeptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning.Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic DiseasesPeroxisome proliferator-activated receptor α ligands and modulators from dietary compounds: Types, screening methods and functions.Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.Heme Oxygenase Induction Suppresses Hepatic Hepcidin and Rescues Ferroportin and Ferritin Expression in Obese Mice.Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.Inhibition of Soluble Epoxide Hydrolase 2 Ameliorates Diabetic Keratopathy and Impaired Wound Healing in Mouse Corneas.
P2860
Q33847244-649F1FB1-5A4B-4EC7-9BA0-099AFD28B451Q34506020-1589C19A-8F25-4292-AF5A-F9670DE6928EQ35172679-D2181604-8F13-4DC6-B09E-62D03EC418A2Q36850263-5F09D6D4-E735-408B-8427-C47ACF89D49AQ36911098-AB81320D-D05B-45CF-A7E6-F336F86F31C5Q37081125-8C6C9321-9E57-4AAB-B954-91510FB03F0DQ37394751-66B93AEB-19BF-4C5D-997B-DAF5D05308FDQ38138158-352CC603-8827-405C-93A8-81EB9FFAD850Q38763928-E27C2CFB-CE45-4034-836D-156D78D64FD6Q39013200-3FE739CA-0915-4E38-8D85-D4032AF50F67Q41143647-91A418CA-1104-4D5A-869F-22316D100D06Q43373032-35580BDF-601D-4C9E-93A6-89257EC280F1Q50109203-9F20D6B2-E0AB-4C20-8728-13171AC91E74Q52609150-769972F9-7D77-45C9-9CB0-C75E33A9A9CF
P2860
Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Epoxyeicosatrienoic acids and ...... tabolic syndrome complications
@ast
Epoxyeicosatrienoic acids and ...... tabolic syndrome complications
@en
type
label
Epoxyeicosatrienoic acids and ...... tabolic syndrome complications
@ast
Epoxyeicosatrienoic acids and ...... tabolic syndrome complications
@en
prefLabel
Epoxyeicosatrienoic acids and ...... tabolic syndrome complications
@ast
Epoxyeicosatrienoic acids and ...... tabolic syndrome complications
@en
P2093
P2860
P1476
Epoxyeicosatrienoic acids and ...... tabolic syndrome complications
@en
P2093
Angela Burgess
Lars Bellner
Luca Vanella
Michal L Schwartzman
Nader G Abraham
P2860
P356
10.1016/J.PROSTAGLANDINS.2011.10.002
P577
2011-11-15T00:00:00Z